Asoy, Jonelyn G.

HRN: 28-91-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/21/2026
06/22/2026
IV
500mg
Q8hr
Sp PLTCS; THICKLY MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: